The Manila Times on MSN16h
Drug war victims asked to submit views and concerns in Duterte case
VICTIMS of former president Rodrigo Duterte's war on drugs are encouraged to submit their views and concerns in the ...
FDA Approves New Prostate Cancer Imaging Agent Gozellix®
Gozellix®, after radiolabeling with 68 Ga, is indicated for PET scanning of PSMA positive lesions in men with prostate cancer who have suspected metastasis and are candidates for initial definitive ...
Philippine News Agency1d
FDA intensifies health supplements regulation for consumer safety
The Food and Drug Administration (FDA) has collaborated with the Health and Dietary Supplement Association of the Philippines ...
Novartis2d
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G)
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...
Quality Assurance & Food Safety2d
FDA Intends to Extend Compliance Date for Food Traceability Rule
The U.S. Food and Drug Administration (FDA) announced its intention to extend the compliance date for the Food Traceability ...
Rheumatology Advisor3d
FDA Approves Cortrophin Gel in Prefilled Syringe Presentation
The FDA has approved Purified Cortrophin Gel (repository corticotropin injection USP) in a prefilled syringe presentation.
Zacks Investment Research on MSN3d
FDA Accepts RDY & ALVO's Prolia & Xgeva Biosimilar BLA for Review
Dr. Reddy’s Laboratories RDY and partner, Alvotech ALVO, announced the FDA’s acceptance of a regulatory filing, seeking the ...
American Hospital Association4d
AHA Comments on DEA Proposed Rule on Special Registrations for Telemedicine Prescribing
AHA comments regarding the Drug Enforcement Administration’s proposed rule for Special Registrations for Telemedicine and Limited State Telemedicine Registrations.
Alvotech and Dr. Reddy’s Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...
PAGEONE6d
FDA, DTI To Improve Supply Chain Processes For MSMEs
Together, FDA and DTI are committed to enhancing supply chains for MSMEs, reflecting their role in local economic growth.
New Telegraph8d
Product Registration: NAFDAC uncovers $1.4m fraud scheme targeting foreign firms
Share The National Agency for Food and Drug Administration and Control (NAFDAC) has exposed a $1.4 million international ...